Louis R Lewandowski1, Amy C Weintrob, David R Tribble, Carlos J Rodriguez, Joseph Petfield, Bradley A Lloyd, Clinton K Murray, Daniel Stinner, Deepak Aggarwal, Faraz Shaikh, Benjamin K Potter. 1. *Department of Orthopaedics, Walter Reed National Military Medical Center, Bethesda, MD; †Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD; ‡Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD; §The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD; ‖Department of Orthopaedics and Rehabilitation, San Antonio Military Medical Center, JBSA Fort Sam Houston, TX; ¶Landstuhl Regional Medical Center, Landstuhl, Germany; and **Infectious Disease Service, San Antonio Military Medical Center, Houston, TX (B. A. Lloyd is now with San Antonio Military Medical Center, JBSA Fort Sam Houston, TX).
Abstract
OBJECTIVE: Clinicians have anecdotally noted that combat-related invasive fungal wound infections (IFIs) lead to residual limb shortening, additional days and operative procedures before initial wound closure, and high early complication rates. We evaluated the validity of these observations and identified risk factors that may impact time to initial wound closure. DESIGN: Retrospective review and case-control analysis. SETTING: Military hospitals. PATIENTS/PARTICIPANTS: US military personnel injured during combat operations (2009-2011). The IFI cases were identified based on the presence of recurrent, necrotic extremity wounds with mold growth in culture, and/or histopathologic fungal evidence. Non-IFI controls were matched on injury pattern and severity. In a supplemental matching analysis, non-IFI controls were also matched by blood volume transfused within 24 hours of injury. INTERVENTION: None. MAIN OUTCOME MEASUREMENTS: Amputation revision rate and loss of functional levels. RESULTS: Seventy-one IFI cases (112 fungal-infected extremity wounds) were identified and matched to 160 control patients (315 non-IFI extremity wounds). The IFI wounds resulted in significantly more changes in amputation level (P < 0.001). Additionally, significantly (P < 0.001) higher number of operative procedures and longer duration to initial wound closure were associated with IFI. A shorter duration to initial wound closure was significantly associated with wounds lacking IFIs (Hazard ratio: 1.53; 95% confidence interval, 1.17-2.01). The supplemental matching analysis found similar results. CONCLUSIONS: Our analysis indicates that IFIs adversely impact wound healing and patient recovery, requiring more frequent proximal amputation revisions and leading to higher early complication rates. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
OBJECTIVE: Clinicians have anecdotally noted that combat-related invasive fungal wound infections (IFIs) lead to residual limb shortening, additional days and operative procedures before initial wound closure, and high early complication rates. We evaluated the validity of these observations and identified risk factors that may impact time to initial wound closure. DESIGN: Retrospective review and case-control analysis. SETTING: Military hospitals. PATIENTS/PARTICIPANTS: US military personnel injured during combat operations (2009-2011). The IFI cases were identified based on the presence of recurrent, necrotic extremity wounds with mold growth in culture, and/or histopathologic fungal evidence. Non-IFI controls were matched on injury pattern and severity. In a supplemental matching analysis, non-IFI controls were also matched by blood volume transfused within 24 hours of injury. INTERVENTION: None. MAIN OUTCOME MEASUREMENTS: Amputation revision rate and loss of functional levels. RESULTS: Seventy-one IFI cases (112 fungal-infected extremity wounds) were identified and matched to 160 control patients (315 non-IFI extremity wounds). The IFI wounds resulted in significantly more changes in amputation level (P < 0.001). Additionally, significantly (P < 0.001) higher number of operative procedures and longer duration to initial wound closure were associated with IFI. A shorter duration to initial wound closure was significantly associated with wounds lacking IFIs (Hazard ratio: 1.53; 95% confidence interval, 1.17-2.01). The supplemental matching analysis found similar results. CONCLUSIONS: Our analysis indicates that IFIs adversely impact wound healing and patient recovery, requiring more frequent proximal amputation revisions and leading to higher early complication rates. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
Authors: Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh Journal: Clin Infect Dis Date: 2005-07-29 Impact factor: 9.079
Authors: James R Dunne; Jason S Hawksworth; Alexander Stojadinovic; Fred Gage; Doug K Tadaki; Philip W Perdue; Jonathan Forsberg; Tom Davis; John W Denobile; Trevor S Brown; Eric A Elster Journal: J Trauma Date: 2009-04
Authors: Grant V Bochicchio; Lena Napolitano; Manjari Joshi; Kelly Bochicchio; Walter Meyer; Thomas M Scalea Journal: World J Surg Date: 2008-10 Impact factor: 3.352
Authors: Anuradha Ganesan; Justin Wells; Faraz Shaikh; Philip Peterson; William Bradley; M Leigh Carson; Joseph L Petfield; Mary Klassen-Fischer; Kevin S Akers; Kevin Downing; Ralf Bialek; David R Tribble; Brian L Wickes Journal: J Clin Microbiol Date: 2019-12-23 Impact factor: 5.948
Authors: Tyler E Warkentien; Faraz Shaikh; Amy C Weintrob; Carlos J Rodriguez; Clinton K Murray; Bradley A Lloyd; Anuradha Ganesan; Deepak Aggarwal; M Leigh Carson; David R Tribble Journal: J Clin Microbiol Date: 2015-05-13 Impact factor: 5.948
Authors: David R Tribble; Clinton K Murray; Bradley A Lloyd; Anuradha Ganesan; Katrin Mende; Dana M Blyth; Joseph L Petfield; Jay McDonald Journal: Mil Med Date: 2019-11-01 Impact factor: 1.437
Authors: Benjamin K Potter; Jonathan A Forsberg; Elizabeth Silvius; Matthew Wagner; Vivek Khatri; Seth A Schobel; Arnaud J Belard; Amy C Weintrob; David R Tribble; Eric A Elster Journal: Mil Med Date: 2019-01-01 Impact factor: 1.437
Authors: Rae A Heitkamp; Ping Li; Katrin Mende; Samandra T Demons; David R Tribble; Stuart D Tyner Journal: Surg Infect (Larchmt) Date: 2017-12-20 Impact factor: 2.150
Authors: Ret Carlos J Rodriguez; Anuradha Ganesan; Faraz Shaikh; M Leigh Carson; William Bradley; Tyler E Warkentien; David R Tribble Journal: Mil Med Date: 2022-05-04 Impact factor: 1.563
Authors: Sebastian Wurster; Alexander M Tatara; Nathaniel D Albert; Ashraf S Ibrahim; Joseph Heitman; Soo Chan Lee; Amol C Shetty; Carrie McCracken; Karen T Graf; Antonios G Mikos; Vincent M Bruno; Dimitrios P Kontoyiannis Journal: mBio Date: 2020-06-30 Impact factor: 7.867
Authors: Anuradha Ganesan; Faraz Shaikh; William Bradley; Dana M Blyth; Denise Bennett; Joseph L Petfield; M Leigh Carson; Justin M Wells; David R Tribble Journal: Emerg Infect Dis Date: 2019-09 Impact factor: 6.883